Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03634540
Title A Trial of PT2977 in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Peloton Therapeutics, Inc.
Indications

renal cell carcinoma

Therapies

Belzutifan + Cabozantinib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
USC Norris Comprehensive Cancer Center ( Site 0060) Recruiting Los Angeles California 90033 United States Details
Cedars Sinai Medical Center Samuel Oschin Comp. Cancer Institute ( Site 0003) Recruiting Los Angeles California 90048 United States Details
Sylvester Comprehensive Cancer Center ( Site 0023) Recruiting Miami Florida 33136 United States Details
Dana Farber Cancer Center ( Site 0006) Recruiting Boston Massachusetts 02215 United States Details
Karmanos Cancer Institute ( Site 0033) Recruiting Detroit Michigan 48201 United States Details
Tennessee Oncology, PLLC ( Site 0024) Recruiting Chattanooga Tennessee 37404 United States Details
Tennessee Oncology, PLLC ( Site 0001) Recruiting Nashville Tennessee 37203 United States Details
Texas Oncology-Baylor Charles A. Sammons Cancer Center ( Site 0010) Completed Dallas Texas 75246 United States Details
Swedish Cancer Institute ( Site 0018) Recruiting Seattle Washington 98104 United States Details
Seattle Cancer Care Alliance/Univ of Washington Medical Center ( Site 0035) Recruiting Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field